Sales rise 4.03% to Rs 16.52 crore
Net Loss of Bafna Pharmaceuticals reported to Rs 34.17 crore in the quarter ended March 2018 as against net loss of Rs 3.44 crore during the previous quarter ended March 2017. Sales rose 4.03% to Rs 16.52 crore in the quarter ended March 2018 as against Rs 15.88 crore during the previous quarter ended March 2017.For the full year,net loss reported to Rs 16.45 crore in the year ended March 2018 as against net loss of Rs 18.47 crore during the previous year ended March 2017. Sales declined 27.39% to Rs 47.17 crore in the year ended March 2018 as against Rs 64.96 crore during the previous year ended March 2017.
ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales16.5215.88 4 47.1764.96 -27 OPM %-198.79-0.76 --74.35-8.04 - PBDT-32.93-2.47 -1233 -10.62-15.42 31 PBT-33.70-3.49 -866 -14.27-19.31 26 NP-34.17-3.44 -893 -16.45-18.47 11
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
